Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew Peter Selwyn, M.D., M.B.Ch.B.

Title
Institution
Department
Address
Phone

Mentoring
completed student projects
Mechanisms and Treatments of Arterial Dysfunction in Atherosclerosis
Part Time/Continuation, 09/07/98 - 01/07/99

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R01HL050016 (SELWYN, ANDREW PETER) Apr 1, 1995 - Feb 29, 2000
    NIH/NHLBI
    TREATMENT OF CORONARY ENDOTHELIAL DYSFUNCTION
    Role: Principal Investigator
  2. N01HV018124 (SELWYN, ANDREW PETER) Dec 10, 1990 - Mar 31, 1994
    NIH/NHLBI
    ASYMPTOMATIC CARDIAC ISCHEMIA PILOT STUDY
    Role: Principal Investigator
  3. R01HL038780 (STONE, PETER HOWARD) Aug 1, 1989 - Jul 31, 2001
    NIH/NHLBI
    VASCULAR BASIS FOR THE TREATMENT OF ISCHEMIA
    Role: Co-Principal Investigator
  4. R01HL035295 (SELWYN, ANDREW PETER) Sep 8, 1986 - Sep 7, 1989
    NIH/NHLBI
    CAUSES OF TRANSIENT ISCHEMIA IN ANGINAL PATIENTS WITH CD
    Role: Principal Investigator
  5. M01RR002635 (GOTTLIEB, GARY L) Dec 1, 1984 - Nov 30, 2004
    NIH/NCRR
    General Clinical Research Center
    Role: Co-Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Campbell P, Leopold JA, Selwyn AP, Sisto D. Equalization of right- and left-sided intracardiac pressures: is it constriction? Circ Heart Fail. 2011 May; 4(3):369-73; discussion 374-7. PMID: 21586737.
    Citations:    Fields:    Translation:Humans
  2. Larose E, Behrendt D, Kinlay S, Selwyn AP, Ganz P, Fang JC. Endothelin-1 is a key mediator of coronary vasoconstriction in patients with transplant coronary arteriosclerosis. Circ Heart Fail. 2009 Sep; 2(5):409-16. PMID: 19808370.
    Citations: 1     Fields:    Translation:Humans
  3. Rawlings R, Nohria A, Liu PY, Donnelly J, Creager MA, Ganz P, Selwyn A, Liao JK. Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event. Am J Cardiol. 2009 Feb 15; 103(4):437-41. PMID: 19195498.
    Citations: 16     Fields:    Translation:Humans
  4. Nohria A, Prsic A, Liu PY, Okamoto R, Creager MA, Selwyn A, Liao JK, Ganz P. Statins inhibit Rho kinase activity in patients with atherosclerosis. Atherosclerosis. 2009 Aug; 205(2):517-21. PMID: 19167712.
    Citations: 38     Fields:    Translation:HumansCells
  5. Selwyn AP. Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update. Am J Cardiol. 2007 Dec 17; 100(12A):33P-37P. PMID: 18154745.
    Citations: 3     Fields:    Translation:Humans
  6. Selwyn AP. Antiatherosclerotic effects of statins: LDL versus non-LDL effects. Curr Atheroscler Rep. 2007 Oct; 9(4):281-5. PMID: 18173955.
    Citations: 1     Fields:    Translation:HumansAnimals
  7. Sacher F, Sobieszczyk P, Tedrow U, Eisenhauer AC, Field ME, Selwyn A, Raymond JM, Koplan B, Epstein LM, Stevenson WG. Transcoronary ethanol ventricular tachycardia ablation in the modern electrophysiology era. Heart Rhythm. 2008 Jan; 5(1):62-8. PMID: 18180021.
    Citations: 16     Fields:    Translation:Humans
  8. Larose E, Kinlay S, Selwyn AP, Yeghiazarians Y, Yucel EK, Kacher DF, Libby P, Ganz P. Improved characterization of atherosclerotic plaques by gadolinium contrast during intravascular magnetic resonance imaging of human arteries. Atherosclerosis. 2008 Feb; 196(2):919-25. PMID: 17391676.
    Citations: 12     Fields:    Translation:Humans
  9. Behrendt D, Beltrame J, Hikiti H, Wainstein M, Kinlay S, Selwyn AP, Ganz P, Fang JC. Impact of coronary endothelial function on the progression of cardiac transplant-associated arteriosclerosis: effect of anti-oxidant vitamins C and E. J Heart Lung Transplant. 2006 Apr; 25(4):426-33. PMID: 16563973.
    Citations: 4     Fields:    Translation:Humans
  10. Larose E, Yeghiazarians Y, Libby P, Yucel EK, Aikawa M, Kacher DF, Aikawa E, Kinlay S, Schoen FJ, Selwyn AP, Ganz P. Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging. Circulation. 2005 Oct 11; 112(15):2324-31. PMID: 16203910.
    Citations: 32     Fields:    Translation:Humans
  11. Stone PH, Lloyd-Jones DM, Kinlay S, Frei B, Carlson W, Rubenstein J, Andrews TC, Johnstone M, Sopko G, Cole H, Orav J, Selwyn AP, Creager MA. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study. Circulation. 2005 Apr 12; 111(14):1747-55. PMID: 15809368.
    Citations: 13     Fields:    Translation:HumansCTClinical Trials
  12. Larose E, Kinlay S, Selwyn A, Yeghiazarians Y, Yucel EK, Kacher D, Aikawa M, Rabkin-Aikawa E, Ganz P. ; Montreal, QC Canada . Intravascular magnetic resonance imaging with Godolinium- DTPA contrast for characterization of atherosclerotic plaques in patients. (Abstract). Can Cardiovascular Congress. 2005.
  13. Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol. 2004 May 19; 43(10):1834-42. PMID: 15145109.
    Citations: 71     Fields:    Translation:Humans
  14. Fernandes JL, Mamoni RL, Orford JL, Garcia C, Selwyn AP, Coelho OR, Blotta MH. Increased Th1 activity in patients with coronary artery disease. Cytokine. 2004 May 07; 26(3):131-7. PMID: 15135807.
    Citations: 22     Fields:    Translation:HumansCells
  15. Stone PH, Lloyd-Jones DM, Johnstone M, Carlson W, Rubenstein J, Creager M, Frei B, Sopko G, Clark ME, Maccallum G, Kinlay S, Orav J, Selwyn AP. Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics. Am Heart J. 2004 May; 147(5):875-82. PMID: 15131545.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  16. Kinlay S, Behrendt D, Fang JC, Delagrange D, Morrow J, Witztum JL, Rifai N, Selwyn AP, Creager MA, Ganz P. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol. 2004 Feb 18; 43(4):629-34. PMID: 14975474.
    Citations: 17     Fields:    Translation:HumansCTClinical Trials
  17. Larose E, Yeghiazarians Y, Selwyn AP, Kinlay S, Yucel EK, Kacher DM, Aikawa M, Rabkin E, Schoen FJ, Libby P, Ganz P. ; . Characterization of atherosclerotic plaques using high-resolution intravascular magnetic resonance imaging. (Abstract). Can J Cardiol. 2004; 20(supplement D)::139D.
  18. Larose E, Behrendt D, Kinlay S, Selwyn A, Ganz P, Fang J. . Endogenous endothelin-1: A potent coronary vasoconstrictor in cardiac transplant recipients with atherosclerosis. (Abstract). Circulation. 2004; 110(17)::III-584.
  19. Larose E, Yeghiazarians Y, Yucel EK, Kacher D, Aikawa M, Rabkin-Aikawa E, Libby P, Kinlay S, Selwyn A, Ganz P. . Intravascular magnetic resonance imaging to characterize the composition of human atherosclerotic in vivo. (Abstract). Circulation. 2004; 110(17)::III-733.
  20. Gonzalez MA, Selwyn AP. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med. 2003 Dec 08; 115 Suppl 8A:99S-106S. PMID: 14678874.
    Citations: 47     Fields:    Translation:Humans
  21. Selwyn AP. Prothrombotic and antithrombotic pathways in acute coronary syndromes. Am J Cardiol. 2003 Jun 19; 91(12A):3H-11H. PMID: 12818729.
    Citations: 10     Fields:    Translation:Humans
  22. Kinlay S, Selwyn AP. Effects of statins on inflammation in patients with acute and chronic coronary syndromes. Am J Cardiol. 2003 Feb 20; 91(4A):9B-13B. PMID: 12615293.
    Citations: 6     Fields:    Translation:Humans
  23. Fang JC, Kinlay S, Behrendt D, Hikita H, Witztum JL, Selwyn AP, Ganz P. Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation. Arterioscler Thromb Vasc Biol. 2002 Dec 01; 22(12):2044-8. PMID: 12482832.
    Citations: 9     Fields:    Translation:HumansCells
  24. Kinlay S, Grewal J, Manuelin D, Fang JC, Selwyn AP, Bittl JA, Ganz P. Coronary flow velocity and disturbed flow predict adverse clinical outcome after coronary angioplasty. Arterioscler Thromb Vasc Biol. 2002 Aug 01; 22(8):1334-40. PMID: 12171797.
    Citations: 1     Fields:    Translation:Humans
  25. Adams MR, Orford JL, Blake GJ, Wainstein MV, Byrne JG, Selwyn AP. Rescue percutaneous coronary intervention following coronary artery bypass graft--a descriptive analysis of the changing interface between interventional cardiologist and cardiac surgeon. Clin Cardiol. 2002 Jun; 25(6):280-6. PMID: 12058791.
    Citations: 4     Fields:    Translation:Humans
  26. Orford JL, Kinlay S, Adams MR, Simon DI, Selwyn AP. Clopidogrel inhibits shear-induced platelet function. Platelets. 2002 May; 13(3):187-9. PMID: 12180502.
    Citations: 1     Fields:    Translation:HumansCells
  27. Fang JC, Kinlay S, Beltrame J, Hikiti H, Wainstein M, Behrendt D, Suh J, Frei B, Mudge GH, Selwyn AP, Ganz P. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet. 2002 Mar 30; 359(9312):1108-13. PMID: 11943259.
    Citations: 29     Fields:    Translation:HumansCTClinical Trials
  28. Baim D, Brady TJ, Casscells SW, Dunne M, Fayad Z, Fuster V, Gazelle S, Heldman A, Hatsukami T, Kinlay S, Lafont A, Lee R, Libby P, Meier B, Muller JE, Naghavi M, O'Donnell C, Perin E, Rekhter M, Rumberger J, Russell M, Schwartz R, Selwyn A, Strauss HW, Tearney G, Tomaru T, Tuzcu EM, Wasserman B. Thoughts on the role of the healing professions and the events of September 11, 2001. Circulation. 2002 Mar 26; 105(12):1509-10. PMID: 11914263.
    Citations:    Fields:    Translation:Humans
  29. Montañez S, Kline AE, Selwyn AP, Suozzi JC, Butler SE, Hernandez TD. Vigabatrin directed against kindled seizures following cortical insult: impact on epileptogenesis and somatosensory recovery. J Neurotrauma. 2001 Nov; 18(11):1255-66. PMID: 11721744.
    Citations:    Fields:    Translation:Animals
  30. Kinlay S, Creager MA, Fukumoto M, Hikita H, Fang JC, Selwyn AP, Ganz P. Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension. 2001 Nov; 38(5):1049-53. PMID: 11711496.
    Citations: 64     Fields:    Translation:Humans
  31. Popma JJ, Hunninghake DB, Arad Y, Blumenthal RS, Boden WE, Selwyn AP. Roundtable discussion: therapeutic challenges and deficiencies. Am J Cardiol. 2001 Oct 18; 88(8A):42K-43K. PMID: 11694219.
    Citations:    Fields:    Translation:Humans
  32. Kinlay S, Behrendt D, Wainstein M, Beltrame J, Fang JC, Creager MA, Selwyn AP, Ganz P. Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries. Circulation. 2001 Sep 04; 104(10):1114-8. PMID: 11535565.
    Citations: 26     Fields:    Translation:Humans
  33. Resnic FS, Blake GJ, Ohno-Machado L, Selwyn AP, Popma JJ, Rogers C. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. Am J Cardiol. 2001 Sep 01; 88(5):493-6. PMID: 11524056.
    Citations: 14     Fields:    Translation:Humans
  34. Resnic FS, Ohno-Machado L, Selwyn A, Simon DI, Popma JJ. Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention. Am J Cardiol. 2001 Jul 01; 88(1):5-9. PMID: 11423050.
    Citations: 14     Fields:    Translation:Humans
  35. Grewal J, Ganz P, Selwyn A, Kinlay S. Usefulness of intravascular ultrasound in preventing stenting of hazy areas adjacent to coronary stents and its support of support spot-stenting. Am J Cardiol. 2001 Jun 01; 87(11):1246-9. PMID: 11377348.
    Citations: 2     Fields:    Translation:Humans
  36. Simon DI, Liu CB, Ganz P, Kirshenbaum JM, Piana RN, Rogers C, Selwyn AP, Popma JJ. A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Catheter Cardiovasc Interv. 2001 Apr; 52(4):425-32. PMID: 11285593.
    Citations: 3     Fields:    Translation:HumansCells
  37. Orford JL, Kinlay S, Fernandes J, Behrendt D, Ganz P, Selwyn AP. Manipulating the vascular biology of coronary atherosclerosis in diabetes: new opportunities. J Lab Clin Med. 2001 Feb; 137(2):82-92. PMID: 11174464.
    Citations:    Fields:    Translation:Humans
  38. Kinlay S, Selwyn AP, Ganz P, O'Gara PT. Lack of compensatory enlargement at sites of coronary vasospasm: identification by ultrasound and successful treatment with stenting. Clin Cardiol. 2000 Nov; 23(11):865-8. PMID: 11097137.
    Citations: 1     Fields:    Translation:Humans
  39. Fang JC, Kinlay S, Wexberg P, Amirzadeh A, Gibson CM, Selwyn AP, Ganz P. Use of the thrombolysis in myocardial infarction frame count for the quantitative assessment of transplant-associated arteriosclerosis. Am J Cardiol. 2000 Oct 15; 86(8):890-2. PMID: 11024410.
    Citations: 2     Fields:    Translation:Humans
  40. Popma JJ, Sawyer M, Selwyn AP, Kinlay S. Lipid-lowering therapy after coronary revascularization. Am J Cardiol. 2000 Aug 24; 86(4B):18H-28H. PMID: 11021252.
    Citations: 1     Fields:    Translation:Humans
  41. Orford JL, Selwyn AP, Ganz P, Popma JJ, Rogers C. The comparative pathobiology of atherosclerosis and restenosis. Am J Cardiol. 2000 Aug 24; 86(4B):6H-11H. PMID: 11021250.
    Citations: 26     Fields:    Translation:HumansAnimals
  42. Fang JC, Kinlay S, Hikita H, Suh JH, Piana RN, Selwyn AP, Frei B, Morrow JD, Ganz P. Relation of preservation of nitric oxide-dependent coronary vasomotor function to plasma vitamin C concentrations in cardiac transplant recipients. Am J Cardiol. 2000 Aug 15; 86(4):460-2. PMID: 10946045.
    Citations:    Fields:    Translation:Humans
  43. Orford JL, Kinlay S, Ganz P, Selwyn AP. Treating ambulatory ischemia in coronary disease by manipulating the cell biology of atherosclerosis. Curr Atheroscler Rep. 2000 Jul; 2(4):321-6. PMID: 11122761.
    Citations:    Fields:    Translation:Humans
  44. Libby P, Aikawa M, Kinlay S, Selwyn A, Ganz P. Lipid lowering improves endothelial functions. Int J Cardiol. 2000 Jun 30; 74 Suppl 1:S3-S10. PMID: 10856767.
    Citations: 3     Fields:    Translation:HumansAnimals
  45. Adams MR, Kinlay S, Blake GJ, Orford JL, Ganz P, Selwyn AP. Pathophysiology of atherosclerosis: development, regression, restenosis. Curr Atheroscler Rep. 2000 May; 2(3):251-8. PMID: 11122751.
    Citations:    Fields:    Translation:Humans
  46. Adams MR, Kinlay S, Blake GJ, Orford JL, Ganz P, Selwyn AP. Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes. Annu Rev Med. 2000; 51:149-67. PMID: 10774458.
    Citations: 6     Fields:    Translation:Humans
  47. Fang JC, Kinlay S, Beltrame JF, Behrendt D, Wainstein MV, Frei B, Morrow JD, Suh JH, Mudge GH, Selwyn AP, Ganz P. . Vitam C and E retard the progression of transplant associated arteriosclerosis: A prospective double-blinded randomized trial. (Abstract). Circulation. 2000; 102::II-488..
  48. Kinlay S, Fang JC, Fukumoto M, Hikita H, Creager MA, Selwyn AP, Ganz P. . Endothelium-derived nitric oxide actively regulates arterial elasticity in humans in vivo. (Abstract). Circulation. 2000; 102::II-120.
  49. Kinlay S, Fang JC, Behrendt D, Wainstein MV, Frei B, Morrow JD, Suh JH, Ganz P, Selwyn AP. . Long-term effect of vitamins E and C on coronary endothelial function: A randomized controlled trial in patients with atherosclerosis. (Abstract) . Circulation. 2000; 102::II-757..
  50. Kinlay S, Fang JC, Behrendt D, Wainstein MV, Frei B, Morrow JD, Suh JH, Ganz P, Selwyn AP. . Long-term effect of vitamins E and C on coronary endothelial function: A randomized controlled trial in patients with atherosclerosis. (Abstract). Circulation. 2000; 102::II-757. .
  51. Kinlay S, Grewal J, Manuelian D, Fang J, Selwyn AP, Bittl JA, Ganz P. . High coronary blood flow velocity and Reynolds number predict clinical outcome after angioplasty. 2000.
  52. Kinlay S, Fang JC, Fukumoto M, Delagrange D, Frei B, Morrow JD, Suh JH, Ganz P, Creager MA, Selwyn AP. . Long-term effect of vitamin C and E on brachial artery endothelial function: A controlled trial in patients with coronary disease. (Abstract). Circulation. 2000; 102::II-81..
  53. Kinlay S, Fang JC, Hikita H, Ho I, Delagrange DM, Frei B, Suh JH, Gerhard M, Creager MA, Selwyn AP, Ganz P. Plasma alpha-tocopherol and coronary endothelium-dependent vasodilator function. Circulation. 1999 Jul 20; 100(3):219-21. PMID: 10411842.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  54. Kinlay S, Selwyn AP, Ganz P. . Endothelium as a target of the risk factors in cardiovascular disease. In:Panza JA, Cannon RO III (eds). Endothelium, nitric oxide, and atherosclerosis. 1999; 17:227-241.
  55. Adams MR, Blake GJ, Kinlay S, Selwyn AP, Ganz P. . Nitric oxide, atherosclerosis and myocardial ischemia. Chapter in Yasue H. Proceedings of the Internal Symposium on Coronary Artery Spasm. 1999.
  56. Beltrame JF, Wainstein MV, Kinlay S, Delagrange DM, Selwyn AP, Ganz P. . The role of endothelin-1 and endothelin-A receptors in the control of coronary tone in humans. 1999.
  57. Simon DI, Selwyn AP, Ganz P, Kirshenbaum JM, Piana RN, Rogers C, Liu CB, Chan S, Popma JJ. . On-site monitoring of shear-induced platetet function during PTCA with IIb/IIIa blockade (Abstract). 1999.
  58. Fang JC, Kinlay S, Hikita H, Witztum JL, Selwyn AP, Ganz P. . An IgG auto-antibody to oxidized LDL is related to impaired coronary endothelial function in patients after cardiac transplantation. 1999.
  59. Fang JC, Kinlay S, Hikita H, Witztum JL, Selwyn AP, Ganz P. cardiac transplantation (Abstract). . An IgG-Auto-antibody to oxidized LDl is related to impaired coronary endothelial function in patients after. Circulation. 1999; 100::I-834.
  60. Beltrame JF, Wainstein MC, Kinlay S, Delagrange DM, Selwyn AP, Ganz P. . The role of endothelin-1 and endothelin-1 receptors in the control of coronary tone in humans. (Abstract). Circulation. 1999; 100::I-830.
  61. Anderson TJ, Meredith IT, Charbonneau F, Ganz P, Selwyn AP. . The role of nitric oxide in coronary artery. In:Gorlin R, Dangas GD, Toutouzas PK, Konstadoulakis MM, eds. Contemporary Concepts in Cardiology. Pathophysiology and Clinical Management. 1999; 7:125-141.
  62. Cooper CJ, Jevnikar FW, Walsh T, Dickinson J, Mouhaffel A, Selwyn AP. The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure. Am J Cardiol. 1998 Sep 01; 82(5):609-14. PMID: 9732889.
    Citations: 12     Fields:    Translation:Humans
  63. Libby P, Schoenbeck U, Mach F, Selwyn AP, Ganz P. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med. 1998 Feb 23; 104(2A):14S-18S. PMID: 9550502.
    Citations: 18     Fields:    Translation:HumansCells
  64. Kinlay S. Selwyn AP, Ganz P. The potential role of the endothelium in acute coronary syndromes:Vasomotion, inflammation, thrombosis. In:Fuster V, ed. The vulnerable aatherosclerotic plaque: Understanding, identification, and modification. 1998; 21:345-357.
  65. Kinlay S, Selwyn AP, Libby P, Ganz P. Inflammation, the endothelium, and the acute coronary syndromes. J Cardiovasc Pharmacol. 1998; 32 Suppl 3:S62-6. PMID: 9883750.
    Citations: 9     Fields:    Translation:Humans
  66. Kinlay S, Fang JC, Hikita H, Delagrange D, Frei B, Suh JP, Gerhard M, Creager MA, Ganz P, Selwyn AP. . Endogenous plasma vitamin E is associated with preserved endothelial function in the coronary arteries of patients with atherosclerosis. (Abstract). Circulation. 1998; 98::I-176a..
  67. Fang JC, Kinlay S, Hikita H, Suh JP, Piana RN, Selwyn AP, Frei B, Ganz P. . Endogenous antioxidant vitamin C is associated with preserved coronary endothelial function in cardiac transplant recipients. (Abstract). Circulation. 1998; 98::I-318..
  68. Kinlay S, Gerhard M, Selwyn AP, Creager MA, Ganz P. . Estrogen’s effects on human coronary and peripheral vasoreactivity. In:Rubanyi GM, Kauffman R, eds. Estrogen and the vessel wall. 1998; 251-260.
  69. Creager MA, Selwyn A. When 'normal' cholesterol levels injure the endothelium. Circulation. 1997 Nov 18; 96(10):3255-7. PMID: 9396409.
    Citations: 2     Fields:    Translation:Humans
  70. Meckel CR, Anderson TJ, Mudge GH, Mitchell RN, Yeung AC, Selwyn AP, Ganz P, Simon DI. Hemostatic/fibrinolytic predictors of allograft coronary artery disease after cardiac transplantation. Vasc Med. 1997 Nov; 2(4):306-12. PMID: 9575604.
    Citations:    Fields:    Translation:Humans
  71. Selwyn AP, Kinlay S, Ganz P. Atherogenesis and ischemic heart disease. Am J Cardiol. 1997 Oct 30; 80(8B):3H-7H. PMID: 9372991.
    Citations: 2     Fields:    Translation:HumansCells
  72. Selwyn AP, Kinlay S, Creager M, Libby P, Ganz P. Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease. Am J Cardiol. 1997 Mar 06; 79(5A):17-23. PMID: 9127617.
    Citations: 8     Fields:    Translation:HumansAnimals
  73. Andrews TC, Raby K, Barry J, Naimi CL, Allred E, Ganz P, Selwyn AP. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation. 1997 Jan 21; 95(2):324-8. PMID: 9008444.
    Citations: 18     Fields:    Translation:HumansCTClinical Trials
  74. Selwyn AP, Kinlay S, Libby P, Ganz P. Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease. Circulation. 1997 Jan 07; 95(1):5-7. PMID: 8994406.
    Citations: 10     Fields: